UoA Prof Explores Ethics of 3D Printing

Stuff covers an interview with Prof. Olaf Diegel, who joined the University of Auckland earlier this year to run a lab that helps NZ industry use 3D printing more intelligently. In this article, he notes the social changes that would come with being able to print replaceable body organs, as well as the impacts that might arise from changes to lifestyle from food printing.

Read more here: https://www.stuff.co.nz/technology/114168331/3d-printing-body-parts-new-tech-raises-ethical-issues

NZ’s first FDA-granted Breakthrough Device

Congratulations to the team at Surgical Design Studio (SDS) and the University of Auckland for achieving a Breakthrough Device designation from the FDA – the first medical device in New Zealand to do so. SDS have a novel device to help those suffering from gastrointestinal diseases, transforming their recoveries from surgery by reducing complications and improving quality of life.

Read more here: https://www.uniservices.co.nz/node/786

Bio-compatible 3D Printing

Professor Olaf Diegel at the University of Auckland talks about recent breakthroughs in additive manufacturing (also known as 3D printing). His team can already print aesthetically pleasing artificial limbs – the technology will soon be there to print organs, including complex organs like livers and kidneys. This would allow medical professionals to print organs to design, suitable for individual patients, rather than relying on organ transplants.

Read more here:

First dual-core biocomputers developed

Researchers at ETH Zurich have used CRISPR methods to develop the first dual-core cell-based biological computer. While biocomputers are relatively slow, the alphabet is much larger and they can use a much larger base system than binary or decimal, at a fraction of the energy cost. While there is still a long way to go before biocomputers can catch up to traditional silicon-based computers, this is exciting progress in this space.

Read more here:

Biomatters Acquired!

A leading provider of DNA data analysis solutions, Auckland-based Biomatters has been acquired by GraphPad, a US publisher of scientific software (particularly around biostatistics). With significant numbers of customers overseas (particularly in the US), the acquisition will help Biomatters take their software to the rest of the world, with a connection through to Insight Partners as well, a leading VC/PE firm investing in high-growth technology and software companies. The sale is great news for Ice Angels and NZVIF, who both held significant stakes in the company.

Read more here: https://www.nzherald.co.nz/business/news/article.cfm?c_id=3&objectid=12225362